The universally prevalent emerging and re-emerging infectious diseases including Ebola, new strains of influenza, or AIDS, or allergies such as asthma, hay fever, and food allergies develop mainly in mucosal tissues in the mouth, digestive organs, respiratory organs, or genitals. Currently, there has been growing interest in studies to understand and control the immune system of mucosal surfaces so that we can prevent and treat these diseases.
Existing injectable vaccines are able to prevent serious conditions, but are not effective enough to defend against infection. Our project has the potential to generate a ”Preventive Vaccine,” which can boost immunity of the body to block the transmission of infectious agents at the entrance of these agents, mucous membrane. This will be the world first Next-generation Vaccine.